HomeLUMO • NASDAQ
add
Lumos Pharma Inc
Previous close
$3.04
Day range
$2.90 - $3.05
Year range
$2.41 - $4.55
Market cap
24.02M USD
Avg Volume
25.09K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 826.00K | 61.33% |
Operating expense | 10.83M | 15.87% |
Net income | -9.46M | -14.67% |
Net profit margin | -1.14K | 28.92% |
Earnings per share | -1.17 | -19.39% |
EBITDA | -9.99M | -13.48% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 36.08M | -46.44% |
Total assets | 40.64M | -43.79% |
Total liabilities | 13.33M | 4.92% |
Total equity | 27.30M | — |
Shares outstanding | 8.11M | — |
Price to book | 0.90 | — |
Return on assets | -56.59% | — |
Return on capital | -78.58% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -9.46M | -14.67% |
Cash from operations | -7.39M | -26.90% |
Cash from investing | 6.17M | 154.34% |
Cash from financing | 742.00K | 256.21% |
Net change in cash | -479.00K | 97.29% |
Free cash flow | -4.16M | -33.30% |
About
Founded
1999
Headquarters
Website
Employees
33